SEC Filing Summary for Actuate Therapeutics, Inc. - Form 4 Filing

This filing details a Form 4 submission for Actuate Therapeutics, Inc. by reporting owner Martin H. Huber Jr., a director. On May 21, 2026, Mr. Huber was granted 15,000 stock options for the company's Common Stock. These options have an exercise price of $2.42 and an expiration date of May 21, 2036. The options will vest in full on the anniversary of the grant date. Following this transaction, Mr. Huber holds 15,000 shares of Common Stock. The filing was signed by Paul Lytle as Attorney-in-Fact on May 22, 2026.